期刊
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY
卷 28, 期 4, 页码 573-583出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.bpg.2014.07.004
关键词
Bile acids; FXR; TGR5; Obesity; Insulin resistance
资金
- Hebei Health Department of Scientific Research Fund
- American Diabetes Association
- DRC (Joslin Diabetes Center) [P30DK036836]
Bile acids are increasingly recognized as key regulators of systemic metabolism. While bile acids have long been known to play important and direct roles in nutrient absorption, bile acids also serve as signalling molecules. Bile acid interactions with the nuclear hormone receptor farnesoid X receptor (FXR) and the membrane receptor G-protein-coupled bile acid receptor 5 (TGR5) can regulate incretin hormone and fibroblast growth factor 19 (FGF19) secretion, cholesterol metabolism, and systemic energy expenditure. Bile acid levels and distribution are altered in type 2 diabetes and increased following bariatric procedures, in parallel with reduced body weight and improved insulin sensitivity and glycaemic control. Thus, modulation of bile acid levels and signalling, using bile acid binding resins, TGR5 agonists, and FXR agonists, may serve as a potent therapeutic approach for the treatment of obesity, type 2 diabetes, and other components of the metabolic syndrome in humans. (C) 2014 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据